MedPath

苏州大冢制药有限公司

Ownership
-
Established
2007-02-16
Employees
-
Market Cap
-
Website
www.suzhou-otsuka.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Cefazolin Sodium for Injection/Sodium Chloride Injection

Product Name
注射用头孢唑林钠/氯化钠注射液
Approval Number
国药准字H20184118
Approval Date
Mar 23, 2023
NMPA

Cefmetazole Sodium for Injection/Sodium Chloride Injection

Product Name
注射用头孢美唑钠/氯化钠注射液
Approval Number
国药准字H20203730
Approval Date
Dec 29, 2020
NMPA

Cefepime Hydrochloride for Injection/Sodium Chloride Injection

Product Name
注射用盐酸头孢吡肟/氯化钠注射液
Approval Number
国药准字H20203071
Approval Date
Mar 3, 2020
NMPA

Cefepime Hydrochloride for Injection/Sodium Chloride Injection

Product Name
注射用盐酸头孢吡肟/氯化钠注射液
Approval Number
国药准字H20203070
Approval Date
Mar 3, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.